Chemotherapy-induced hair loss might soon become a thing of the past, thanks to Luminate Medical

By Malavika Pradeep

Published Sep 1, 2021 at 09:30 AM

Reading time: 2 minutes

Hair loss is one of the most recognisable side effects of chemotherapy affecting millions of cancer patients annually. With 47 per cent of female patients considering hair loss to be the most traumatic aspect of chemotherapy and 8 per cent of them declining the entire treatment for fear of hair loss, Luminate Medical is dedicating itself to provide a patient-focused alternative—thereby uprooting all visible connections of the side effect from the treatment.

Co-founded by Aaron Hannon and Doctor Bárbara Oliveira, Luminate Medical’s groundbreaking venture (dubbed LILY) is a wearable device that will use electrical stimulation to curb the visible side effect. When a patient undergoes chemotherapy, the cancer-inhibiting drugs courses through their entire body—travelling absolutely everywhere blood does. This, in turn, results in a variety of side effects like weakness and nausea, along with significant hair loss when the substances affect follicles in the long run. Developed in collaboration with the Translational Medical Device Lab at the National University of Ireland, Galway, Luminate Medical’s solution is to prevent blood from reaching those cells in the first place.

The portable device works as a mechanised compression garment for the head using soft materials to achieve the pressure. According to Hannon, the device is therefore comfortable with the pressure being carefully monitored. There’s also no risk of damage from the lack of blood flow in those cells.

“Compression therapy has been really well studied,” he said in an interview with TechCrunch. “There are years of literature around how long you can apply these therapies without damaging the cells. There’s a certain amount of mechanical engineering involved in making it both comfortable and effective.”

Chemotherapy-induced hair loss might soon become a thing of the past, thanks to Luminate Medical

Patients are required to wear the cap during and after the entire chemo session. By restricting blood flow to the skin of the scalp, the novel device facilitates the flow of the drugs to the intended tumor or cancer site while saving hair follicles from damage. To date, Luminate Medical has performed animal trials—which saw strong hair retention of around 80 per cent with no adverse effects. Although full-fledged human trials require more time and approval to set up, initial tests of the wearable devices’ effects on healthy patients have proven to work exactly as expected on humans.

“We’re really excited about the efficacy of this therapy because it works with lots of hair types,” Hannon said—highlighting inclusivity as an important yet underestimated factor when it comes to innovations in healthcare. The company also backs the belief that no patient should have to compromise their identity to get the best available medical treatment. “Luminate Medical recognises that hair is an essential element of personality and self-esteem, and is dedicated to using the latest advances in medical technology to protect this,” the company website reads.

When it comes to competition, Hannon noted the presence of new treatments that cool the scalp instead of compressing it. However, the CEO added how patients predominantly engage in the purchase of wigs to counter the side effect. Given the fact that wigs are covered and hair loss is considered a medical condition by many insurance companies and other methods of reimbursement, TechCrunch noted how it will take time and evidence to get the device approved for those processes.

The team, however, is confident that the solution—valued at around $1,500—is within the means of many as long as other costs are being picked up by insurance coverage. After all, people spend fortunes on wigs and other hair retention products and methods. Who wouldn’t prefer prevention over cure in the first place? Luminate Medical is also seeking to offer the benefits of the device to those who can’t afford the cost out of pocket—therefore progressing toward FDA approval and a US launch with Europe and others to come. At the moment, the team is focused on getting the device into the hands (and onto the heads) of its first set of patients.

Chemotherapy-induced hair loss might soon become a thing of the past, thanks to Luminate Medical

Keep On Reading

By Fatou Ferraro Mboup

Is Kylie Jenner broke? New conspiracy theory suggests the billionaire might be out of cash

By Fatou Ferraro Mboup

Annie Leibovitz’s Zendaya Vogue shoot reignites call for Black photographers

By Abby Amoakuh

British homes for British workers: Tory party pushes new controversial housing scheme

By Abby Amoakuh

TikTok momfluencer Jacquelyn faces new safety concern allegations for toddler Wren Eleanor

By Louis Shankar

Nex Benedict’s tragic death proves the US and UK have learnt nothing about inclusivity in schools

By Abby Amoakuh

Anti-abortion OBGYN who said 9-year-olds are fine to give birth appointed to maternal death committee

By Abby Amoakuh

Grave site for Megan Thee Stallion’s mother ramps up security after Nicki Minaj fans leak location

By Abby Amoakuh

Crunchy, silky, scrunchie and almond moms: What’s behind TikTok’s latest parenting craze?

By Abby Amoakuh

Netizens mock Kim Kardashian after mega cringe Actors on Actors interview with Chloë Sevigny

By Fatou Ferraro Mboup

Selena Gomez accused of plagiarism for the second time by artist

By Abby Amoakuh

Piers Morgan’s shocking interview reveals Fiona Harvey set on suing Netflix and Baby Reindeer creator Richard Gadd

By Fatou Ferraro Mboup

AI-generated images of Donald Trump with Black voters spread before US presidential election

By Charlie Sawyer

Dan Schneider addresses accusations revealed in Quiet on Set: The Dark Side of Kids TV 

By Fatou Ferraro Mboup

Two duvets, one love: How the Scandinavian sleep method transformed my nights

By Abby Amoakuh

Who is Brit Smith, the smaller artist JoJo Siwa allegedly stole Karma from?

By Fatou Ferraro Mboup

Kansas Chiefs kicker Harrison Butker tells women to stay in the kitchen in commencement speech

By Abby Amoakuh

Ballerina, beauty queen and Mormon: Who is Ballerina Farm owner, Hannah Neeleman?

By Charlie Sawyer

How much is the morning after pill and why are we still paying for it?

By Fleurine Tideman

Your Honor, I’d like to plead the case for Taylor Swift going to the Super Bowl

By Abby Amoakuh

MGK opens up about miscarriage with Megan Fox after couple’s short-lived break-up